Interstitial pneumonitis secondary to intravesical bacillus calmette-guerin for carcinoma in-situ of the bladder
AUTOR(ES)
Diner, Eric K., Verghese, Mohan
FONTE
International braz j urol
DATA DE PUBLICAÇÃO
2004-10
RESUMO
We report an 81-year-old male who developed severe interstitial pneumonitis on maintenance intravesical Bacillus Calmette-Guerin (BCG) for in-situ carcinoma of the bladder. The patient was treated with steroids and anti-tuberculin therapy with complete response. While there is no established standard of care for the treatment of interstitial pneumonitis, recent reports describe success with combination of corticosteroids and anti-tuberculin medications. We elected to follow this precedent and treated our patient with corticosteroids and anti-tuberculin therapy with good outcome.
Documentos Relacionados
- Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)
- Imaging appearance of granulomatous disease after intravesical Bacille Calmette-Guerin (BCG) treatment of bladder carcinoma
- Bacillus Calmette-Guérin (BCG) Brazilian Backstage in Bladder Cancer
- THE PROPHYLACTIC VALUE OF BACILLUS CALMETTE-GUÉRIN
- Characterization of the internalization of bacillus Calmette-Guerin by human bladder tumor cells.
